SAN DIEGO, Oct. 24, 2022 /PRNewswire/ — Shoreline Biosciences, Inc. (Shoreline), a biopharmaceutical company developing next-generation cellular immunotherapies based on induced pluripotent stem cells (iPSCs) utilizing its proprietary iPSC-derived natural killer (iNK) cell and macrophage…
News Ticker
- [ September 21, 2023 ] The Endpoints 11 2023 winners: Biotech’s most exciting startups News
- [ September 21, 2023 ] Exclusive: AstraZeneca signs off on a ‘carbon negative’ new biotech building for one of its latest buyouts News
- [ September 21, 2023 ] Societal CDMO lays off 26 employees, starts hiring freeze after strategy review News
- [ September 21, 2023 ] Laboratory Technician II – Exagen Inc. – Vista, CA San Diego Biotech Jobs
- [ September 21, 2023 ] Oxford Nanopore moves into mRNA vaccine testing as researchers report faster quality control process News
Copyright © 2023 Biotech Networks, LLC
